|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 371.42 USD | +2.79% |
|
+4.75% | +12.92% |
| 08:26am | Amgen Wins Preliminary Injunction to Block Colorado From Imposing Price Cap on Arthritis Drug | MT |
| 01:41am | Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage Trial | DJ |
| Market Cap | 195B 171B 158B 147B 277B 18,540B 283B 1,896B 734B 9,101B 732B 716B 31,673B | P/E 2026 * |
23.5x | P/E 2027 * | 21.7x |
|---|---|---|---|---|---|
| Enterprise Value | 237B 208B 191B 178B 336B 22,505B 343B 2,301B 892B 11,047B 889B 870B 38,446B | EV / Sales 2026 * |
6.27x | EV / Sales 2027 * | 5.97x |
| Free-Float |
99.78% | Yield 2026 * |
2.79% | Yield 2027 * | 2.95% |
Last Transcript: Amgen Inc.
| 1 day | +0.81% | ||
| 1 week | +2.82% | ||
| Current month | -0.22% | ||
| 1 month | +9.78% | ||
| 3 months | +2.28% | ||
| 6 months | +10.39% | ||
| Current year | +10.39% |
| 1 week | 354.16 |  | 364 |
| 1 month | 325.98 | | 364 |
| Current year | 318.21 | | 391.29 |
| 1 year | 269.77 | | 391.29 |
| 3 years | 218.44 | | 391.29 |
| 5 years | 198.64 | | 391.29 |
| 10 years | 133.64 | | 391.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 63 | 2012-04-30 |
| Director of Finance/CFO | 62 | 2010-05-12 | |
Peter Griffith
DFI | Director of Finance/CFO | 67 | 2019-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CHM | Chairman | 63 | 2012-12-31 |
Tyler Jacks
BRD | Director/Board Member | 65 | 2011-12-31 |
Robert Eckert
BRD | Director/Board Member | 71 | 2011-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| May. 18 | Free | Director | 665 | 0.0001% | ||
| May. 18 | Free | Director | 665 | 0.0001% | ||
| May. 18 | Free | Director | 665 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.67% | +2.82% | +24.37% | +62.75% | 195B | |
| +0.09% | +6.67% | +53.59% | +154.11% | 1,063B | |
| +0.63% | +5.39% | +62.89% | +53.44% | 611B | |
| +0.27% | +6.88% | +32.14% | +86.34% | 444B | |
| +2.52% | -0.96% | +26.12% | +20.22% | 324B | |
| +2.45% | +0.43% | +35.92% | +36.13% | 285B | |
| +1.04% | +0.10% | +28.13% | +42.44% | 283B | |
| +1.04% | +2.90% | -26.43% | -40.00% | 219B | |
| +0.64% | +0.65% | +12.75% | +63.45% | 156B | |
| +1.74% | -0.67% | -4.63% | -34.90% | 136B | |
| Average | +1.14% | +2.29% | +24.49% | +44.40% | 371.68B | |
| Weighted average by Cap. | +0.89% | +3.91% | +36.78% | +73.26% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 37.76B 33.16B 30.52B 28.44B 53.63B 3,590B 54.72B 367B 142B 1,762B 142B 139B 6,133B | 38.71B 33.99B 31.29B 29.15B 54.98B 3,681B 56.1B 376B 146B 1,807B 145B 142B 6,288B |
| Net income | 8.23B 7.23B 6.65B 6.2B 11.69B 783B 11.93B 80.01B 31B 384B 30.91B 30.24B 1,337B | 8.86B 7.78B 7.16B 6.68B 12.59B 843B 12.85B 86.17B 33.39B 414B 33.28B 32.56B 1,440B |
| Net Debt | 41.7B 36.62B 33.7B 31.41B 59.23B 3,965B 60.43B 405B 157B 1,946B 157B 153B 6,773B | 36.06B 31.66B 29.14B 27.15B 51.21B 3,428B 52.25B 350B 136B 1,683B 135B 132B 5,856B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-02 | $369.32 | +2.21% | 173,983 |
| 26-07-01 | $361.33 | -0.22% | 2,244,791 |
| 26-06-30 | $362.12 | +0.44% | 2,246,908 |
| 26-06-29 | $360.55 | +0.62% | 2,461,887 |
| 26-06-26 | $358.33 | +1.56% | 3,610,561 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMGN Stock
Select your edition
All financial news and data tailored to specific country editions
